Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 3
2007 1
2008 1
2009 1
2010 2
2011 6
2012 7
2013 2
2014 4
2015 5
2016 3
2017 1
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Anti-factor VIII antibodies: a 2005 update.
Lavigne-Lissalde G, Schved JF, Granier C, Villard S. Lavigne-Lissalde G, et al. Thromb Haemost. 2005 Oct;94(4):760-9. doi: 10.1160/TH05-02-0118. Thromb Haemost. 2005. PMID: 16270627 Review.
Pain management in patients with haemophilia: a European survey.
Holstein K, Klamroth R, Richards M, Carvalho M, Pérez-Garrido R, Gringeri A; European Haemophilia Therapy Standardization Board. Holstein K, et al. Haemophilia. 2012 Sep;18(5):743-52. doi: 10.1111/j.1365-2516.2012.02808.x. Epub 2012 Apr 25. Haemophilia. 2012. PMID: 22530627 Review.
Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations.
Hermans C, De Moerloose P, Fischer K, Holstein K, Klamroth R, Lambert T, Lavigne-Lissalde G, Perez R, Richards M, Dolan G; European Haemophilia Therapy Standardisation Board. Hermans C, et al. Among authors: lavigne lissalde g. Haemophilia. 2011 May;17(3):383-92. doi: 10.1111/j.1365-2516.2010.02449.x. Epub 2011 Feb 15. Haemophilia. 2011. PMID: 21323794 Review.
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.
Astermark J, Altisent C, Batorova A, Diniz MJ, Gringeri A, Holme PA, Karafoulidou A, Lopez-Fernández MF, Reipert BM, Rocino A, Schiavoni M, von Depka M, Windyga J, Fijnvandraat K; European Haemophilia Therapy Standardisation Board. Astermark J, et al. Haemophilia. 2010 Sep 1;16(5):747-66. doi: 10.1111/j.1365-2516.2010.02231.x. Epub 2010 Apr 14. Haemophilia. 2010. PMID: 20398077 Review.
Neonatal bleeding in haemophilia: a European cohort study.
Richards M, Lavigne Lissalde G, Combescure C, Batorova A, Dolan G, Fischer K, Klamroth R, Lambert T, Lopez-Fernandez M, Pérez R, Rocino A, Fijnvandraat K; European Haemophilia Treatment and Standardization Board. Richards M, et al. Among authors: lavigne lissalde g. Br J Haematol. 2012 Feb;156(3):374-82. doi: 10.1111/j.1365-2141.2011.08967.x. Epub 2011 Dec 7. Br J Haematol. 2012. PMID: 22146054 Free article.
Continuous infusion in haemophilia: current practice in Europe.
Batorova A, Holme P, Gringeri A, Richards M, Hermans C, Altisent C, Lopez-Fernández M, Fijnvandraat K; European Haemophilia Treatment Standardisation Board. Batorova A, et al. Haemophilia. 2012 Sep;18(5):753-9. doi: 10.1111/j.1365-2516.2012.02810.x. Epub 2012 Apr 25. Haemophilia. 2012. PMID: 22530687
Clinical value of automated fibrin generation markers in patients with septic shock: a SepsiCoag ancillary study.
Gris JC, Cochery-Nouvellon E, Bouvier S, Jaber S, Albanese J, Constantin JM, Orban JC, Morel J, Leone M, Deras P, Elotmani L, Lavigne-Lissalde G, Lefrant JY. Gris JC, et al. Among authors: lavigne lissalde g. Br J Haematol. 2018 Nov;183(4):636-647. doi: 10.1111/bjh.15576. Epub 2018 Sep 11. Br J Haematol. 2018. PMID: 30203833 Free article. Clinical Trial.
33 results